摩根中国生物医药混合(QDII)C(019573)资产配置
| 序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
| 1 |
2026-03-31 |
89.55 |
- |
11.59 |
522,163,354.36 |
| 2 |
2025-12-31 |
88.13 |
- |
13.28 |
511,067,433.45 |
| 3 |
2025-09-30 |
86.36 |
- |
15.46 |
633,399,429.09 |
| 4 |
2025-06-30 |
93.10 |
- |
7.58 |
501,022,355.85 |
| 5 |
2025-03-31 |
84.78 |
- |
15.85 |
468,301,563.49 |
| 6 |
2024-12-31 |
82.48 |
- |
18.72 |
409,944,137.20 |
| 7 |
2024-09-30 |
80.38 |
- |
20.22 |
464,299,734.53 |
| 8 |
2024-06-30 |
74.76 |
- |
23.57 |
433,040,096.77 |
| 9 |
2024-03-31 |
66.31 |
- |
34.64 |
468,005,968.71 |
| 10 |
2023-12-31 |
77.78 |
- |
22.87 |
537,409,054.02 |
| 11 |
2023-09-30 |
58.75 |
- |
22.65 |
565,317,366.94 |
微信公众号
证券之星APP
基本资料
